New Results
Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine induces equivalent preclinical antibody titers and viral neutralization to recovered COVID-19 patients
Paul F. McKay, Kai Hu, Anna K. Blakney, Karnyart Samnuan, Clément R. Bouton, Paul Rogers, Krunal Polra, Paulo J.C. Lin, Christopher Barbosa, Ying Tam, Robin J. Shattock
doi: https://doi.org/10.1101/2020.04.22.055608
Paul F. McKay
1Department of Infectious Diseases, Imperial College London, Norfolk Place, London, United Kingdom W2 1PG
Kai Hu
1Department of Infectious Diseases, Imperial College London, Norfolk Place, London, United Kingdom W2 1PG
Anna K. Blakney
1Department of Infectious Diseases, Imperial College London, Norfolk Place, London, United Kingdom W2 1PG
Karnyart Samnuan
1Department of Infectious Diseases, Imperial College London, Norfolk Place, London, United Kingdom W2 1PG
Clément R. Bouton
1Department of Infectious Diseases, Imperial College London, Norfolk Place, London, United Kingdom W2 1PG
Paul Rogers
1Department of Infectious Diseases, Imperial College London, Norfolk Place, London, United Kingdom W2 1PG
Krunal Polra
1Department of Infectious Diseases, Imperial College London, Norfolk Place, London, United Kingdom W2 1PG
Paulo J.C. Lin
2Acuitas Therapeutics, Vancouver, British Columbia, Canada, V6T 1Z3
Christopher Barbosa
2Acuitas Therapeutics, Vancouver, British Columbia, Canada, V6T 1Z3
Ying Tam
2Acuitas Therapeutics, Vancouver, British Columbia, Canada, V6T 1Z3
Robin J. Shattock
1Department of Infectious Diseases, Imperial College London, Norfolk Place, London, United Kingdom W2 1PG

Article usage
Posted April 25, 2020.
Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine induces equivalent preclinical antibody titers and viral neutralization to recovered COVID-19 patients
Paul F. McKay, Kai Hu, Anna K. Blakney, Karnyart Samnuan, Clément R. Bouton, Paul Rogers, Krunal Polra, Paulo J.C. Lin, Christopher Barbosa, Ying Tam, Robin J. Shattock
bioRxiv 2020.04.22.055608; doi: https://doi.org/10.1101/2020.04.22.055608
Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine induces equivalent preclinical antibody titers and viral neutralization to recovered COVID-19 patients
Paul F. McKay, Kai Hu, Anna K. Blakney, Karnyart Samnuan, Clément R. Bouton, Paul Rogers, Krunal Polra, Paulo J.C. Lin, Christopher Barbosa, Ying Tam, Robin J. Shattock
bioRxiv 2020.04.22.055608; doi: https://doi.org/10.1101/2020.04.22.055608
Subject Area
Subject Areas
- Biochemistry (7567)
- Bioengineering (5522)
- Bioinformatics (20782)
- Biophysics (10325)
- Cancer Biology (7978)
- Cell Biology (11635)
- Clinical Trials (138)
- Developmental Biology (6602)
- Ecology (10200)
- Epidemiology (2065)
- Evolutionary Biology (13611)
- Genetics (9539)
- Genomics (12844)
- Immunology (7919)
- Microbiology (19538)
- Molecular Biology (7657)
- Neuroscience (42081)
- Paleontology (308)
- Pathology (1257)
- Pharmacology and Toxicology (2201)
- Physiology (3267)
- Plant Biology (7038)
- Synthetic Biology (1951)
- Systems Biology (5426)
- Zoology (1116)